Stocks and Investing Stocks and Investing
Tue, October 10, 2017
Mon, October 9, 2017

Charles Duncan Initiated (ALT) at Buy and Held Target at $180 on, Oct 9th, 2017


Published on 2024-10-25 23:17:41 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Piper Sandler, Initiated "Altimmune, Inc." (ALT) at Buy and Held Target at $180 on, Oct 9th, 2017.

Charles, nor any peers, have made any analyst calls on ALT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources